Literature DB >> 11485408

Viral neuraminidase treatment of dendritic cells enhances antigen-specific CD8(+) T cell proliferation, but does not account for the CD4(+) T cell independence of the CD8(+) T cell response during influenza virus infection.

SangKon Oh1, Gabrielle T Belz, Maryna C Eichelberger.   

Abstract

In vitro studies demonstrate that the increased alloreactive T cell response to dendritic cells (DC) that are treated with either live or inactivated influenza virus A/PR/8/34 is due to viral neuraminidase (NA) activity. Since virus-specific cytotoxic T lymphocytes (CTL) play an important role in immunity to heterologous influenza strains, we compared the activation of CD8(+) T cells by untreated and NA-treated DC. Increased CTL activity was induced by NA-treated DC both in vitro and in vivo. Since the generation of CTL in response to influenza virus infection does not require prior "activation" of DC by CD4(+) T cells (as is the case for many antigens), we asked whether NA activity contributed to this unconditional CD8(+) T cell response. This was not the case. Future studies will determine the factors that are responsible for the CD4(+) T-cell-independent influenza virus-specific CTL response. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485408     DOI: 10.1006/viro.2001.0992

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Quantification of the effect of glycocalyx condition on membrane receptor interactions using an acoustic wave sensor.

Authors:  Michael Saitakis; Electra Gizeli
Journal:  Eur Biophys J       Date:  2010-10-17       Impact factor: 1.733

Review 2.  Respiratory dendritic cells: mediators of tolerance and immunity.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Length variations in the NA stalk of an H7N1 influenza virus have opposite effects on viral excretion in chickens and ducks.

Authors:  T W Hoffmann; S Munier; T Larcher; D Soubieux; M Ledevin; E Esnault; A Tourdes; G Croville; J-L Guérin; P Quéré; R Volmer; N Naffakh; D Marc
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Quantification of the frequency and multiplicity of infection of respiratory- and lymph node-resident dendritic cells during influenza virus infection.

Authors:  Rebecca VanoOsten Anderson; Jodi McGill; Kevin L Legge
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

Review 5.  Innate immune control and regulation of influenza virus infections.

Authors:  Jodi McGill; Jonathan W Heusel; Kevin L Legge
Journal:  J Leukoc Biol       Date:  2009-07-30       Impact factor: 4.962

Review 6.  Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine.

Authors:  Luca T Giurgea; David M Morens; Jeffery K Taubenberger; Matthew J Memoli
Journal:  Vaccines (Basel)       Date:  2020-07-23

Review 7.  NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

Authors:  Florian Krammer; Ron A M Fouchier; Maryna C Eichelberger; Richard J Webby; Kathryn Shaw-Saliba; Hongquan Wan; Patrick C Wilson; Richard W Compans; Ioanna Skountzou; Arnold S Monto
Journal:  mBio       Date:  2018-04-03       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.